Metabolic surgery offers significant cardiovascular benefits for patients with diabetes

FHS
June 27, 2023
12:50 pm

Patients with diabetes and a history of metabolic surgery had significantly fewer heart attacks, strokes, hospitalizations and death compared to matched patients who did not have the surgery, according to a new study presented here today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting.

MSD’s Welireg secures FDA approval for renal cell carcinoma – Pharmaceutical Technology

Share this article The FDA based its decision for the second approval of the drug on results from MSD’s LITESPARK-005 trial (NCT04195750). Image credit: Shutterstock/Magic

December 15, 2023

Overtreatment of older men with prostate cancer raises concerns

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly

November 12, 2024

The FDA isn’t afraid to yank a disappointing drug

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.